OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
26 hedge funds and large institutions have $7.22M invested in Ocera Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-10
Holders Change %
-27.78%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
10
Reduced
2
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$2.82M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$1.42M |
| 3 |
HP
3
Hikari Power
Tokyo,
Japan
|
$328K |
| 4 |
4
BlackRock
New York
|
$82K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$73K |
